Anthem Biosciences, established in 2006, is an innovation-driven Contract Research, Development, and Manufacturing Organisation (CRDMO) that offers integrated services in drug discovery, development, and manufacturing. The company specialises in fermentation-based APIs, including probiotics, enzymes, peptides, and biosimilars, catering to both biotech startups and large pharma worldwide. With 196 active projects, including 170 discovery projects, Anthem’s R&D spans RNAi, ADCs, and peptides. The company’s manufacturing facilities, including one under construction, support a broad portfolio of custom synthesis and fermentation capabilities. Known for green chemistry and cutting-edge technologies, Anthem is a leader in delivering sustainable, high-quality solutions across regulated markets.
Apply for Anthem Biosciences Ltd. IPO in three easy steps:
1
Login to InvestMentor IPO Portal
2
Enter your bid details and UPI ID
3
Accept mandate using your UPI enabled app